CRT 2025
Coronary
Coronary Imaging
Adnan Kastrati, MD
Senior Consultant, Head of Catheterization Laboratory
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany
Disclosure(s): No financial relationships to disclose
Katherine Kunkel, MD
Interventional Cardiologist
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure information not submitted.
Ryan D. Madder, MD
Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
Corewell Health
Ada, Michigan, United States
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus: Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Grant/Research Support (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Ziad Ali, MD, DPhil
Director
DeMatteis Cardiovascular Institute
Columbia University
Roslyn, New York, United States
Disclosure information not submitted.
Yuhei Kobayashi, MD
Assistant Professor
NY Presbyterian Brooklyn Methodist Hospital/Weill Cornell Medical College, New York, United States
Disclosure(s): CathWorks: Grant/Research Support (Ongoing)
Gary S. Mintz, MD
Senior Medical Advisor
Cardiovascular Research Foundation
Washington, District of Columbia, United States
Disclosure information not submitted.
Andrew SP Sharp, MD
Professor of Cardiology
University College Dublin
Dublin, Ireland
Disclosure information not submitted.
Gregg W. Stone, MD, FACC, MSCAI
Physician
Mount Sinai
New York, New York, United States
Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)